キーワード索引

[A]
ACE inhibitor SL-2
acetylcholine S-2-3, S-2-4
acetylcholinesterase S-2-4
acidic pH     P-4
adenoviral vector       O-3-1
adipose tissue S-1-3
adrenomedulline P-7
ageing O-3-6
agonist S-1-3
α1D receptor P-16
Alzheimer's disease S-2-3, S-2-4
amyloid β-peptides S-2-3
angiogenesis S-1-1
angiotensin converting enzyme S-3-1
angiotensinogen S-3-1
animal disease model O-3-4
ankyrin repeat O-3-5
antioxidative defense P-1
antipsychotic agent S-2-2
antipsychotic drug P-9
antisense methods O-3-1
antithrombotic drug SL-2
aorta     P-5
ATA2     P-18
ATP     P-9, P-19
ATP sensitive potassium channel opener P-2
ATPase O-3-6
atypical β-adrenoceptor P-8
ATZ1993 O-1-1
avoidance ability     P-1

[B]
β-funaltrexamine P-10
β-secretases S-2-3
β3-adrenergic receptor S-1-3
β3-adrenoceptor P-8
bioinformatics S-3-2
bisphosphonates O-2-5
blood testis barrier P-17
blood-brain barrier P-18, P-19
BRL37344     O-1-3

[C]
CD38     EL
Ca2+ channel P-7
Ca2+-dependent K+ channel S-1-4
Ca2+ overload S-1-4
calcineurin     O-3-2
calcium O-3-2, P-3
calcium release P-4
capsaicin test P-11
cardiac cells P-7
cardiac protection S-1-2
cardiac remodeling S-1-2
cardiotonics S-1-2
catecholamine biosynthesis O-3-5
Cbfa1 O-2-5
cDNA microarray O-3-4
chicken essence P-12
cholinergic hypothesis S-2-4
cloned human β3-adrenergic receptor O-1-3
clozapine     P-9
cognitive dysfunction P-14
conditionally immortalized cell lines P-19
congestive heart failure     S-1-2
constitutive activity O-1-3
contractile responses P-6
creatine     P-19
cyclic ADP-ribose EL

[D]
D2 antagonist S-2-2
DNA     S-1-1
DNA microarray S-3-2
DNA replication O-3-6
DOPA O-2-2
decoy S-1-1
dementia     P-1
depression     O-2-3
dermorphin tetrapeptide analogue P-10
developing molecular biology SL-3
diabetes mellitus     O-1-4
diet     P-12
differentiation P-6
docosahexaenoic acid P-1
donepezil     S-2-4
dopamine D4receptor P-9
down-regulation O-3-1
drug metabolizing enzyme S-3-4
ductus arteriosus     O-1-1

[E]
ectopic bone formation O-2-4
endothelin     SL-1, O-1-1
endothelin antagonist SL-1
endothelin receptor O-1-2
endothelin receptor type A O-1-1
endothelium O-1-4
evidence-based medicine S-3-3

[F]
18F-fluorodeoxyglucose (FDG) P-13

[G]
γ-secretases S-2-3
gene expression O-2-4, O-3-2
gene polymorphisms S-3-1
gene targeting S-2-1
gene therapy S-1-1, S-1-2
genetic P-20
genome sciences SL-3
genotype     S-3-4
glial cells     O-2-1
glutamate     O-2-2
growth factor   O-3-4
guinea pig duodenum P-8
guinea pig gastric fundus P-8

[H]
5-HT1A partial agonist S-2-2
5-HT2 antagonist     S-2-2
5-HT2 receptor family P-15
5-HT2A receptor P-16
5-HT2A subtype P-15
HERG O-1-5
heme-oxygenase-1 SL-2
histamine     P-12
hyperactivity P-12
hypertension S-3-1
hypoxia P-5

[I]
IgA nephropathy O-3-4
impairment of cell        P-3
impairment of learning O-2-3
inducible NO synthase O-3-3
information biology SL-3
insulin O-1-4, P-20
interleukin-1 O-3-3
intestine     P-5
ischemia     O-2-2, P-5
isoproterenol O-1-3

[K]
K+ channel opener S-1-4
KKAy mouse P-20

[L]
LOE908 O-1-2

[M]
MCC-134 P-2
mechanical stress O-2-4
methanesulfonanilide compounds O-1-5
mice O-2-3, P-14
molecular modeling P-15
morphine     P-11
mRNA stability O-3-3
muscarinic receptor O-2-3
myosin light chain kinase O-3-1
μ-opioid receptor P-10

[N]
N-5984 O-1-3
NF-κB O-2-1
NFAT     O-3-2
NFIL3/E4BP4 O-3-2
naloxonazine P-10
natural killer cell activity (NKA) P-13
nantenine derivatives P-16
negative symptoms P-14
nerve growth factor O-2-1
neural stem cells     P-6
neuronal cell death O-2-2
neuroprotection S-1-4
nitric oxide (NO)     O-1-4
nociceptin     P-11
nociceptin(1-13)     P-11
nociceptin(1-13)NH2 P-11
non-steroidal bone anabolic drugs O-2-5
nonselective cation channel O-1-2
normalized cDNA library O-3-4

[O]
obesity S-1-3
organ protection     P-2
organic ion     P-17
osmotic regulation P-18
ossification of the posterior longitudinal ligament O-2-4

[P]
p38 MAP kinase O-3-3
PACAP S-2-1, P-20
PTH(1-34)     O-2-5
palmitoylcarnitine     P-3
perospirone     S-2-2
personalized medicine S-3-3
pharmacogenomics S-3-1, S-3-2, S-3-3
pharmainformatics S-3-2
phencyclidine P-13
plasmid vector O-3-1
poly(ADP-ribose) synthetase/polymerase (PARP) EL
positive inotropic action P-7
positron emission tomography (PET) P-13
pravastatin     O-1-4
protein kinase C-ζ O-2-1
psycho-oncology     P-13
psychotic disorder S-2-1
pulmonary vessels P-5

[R]
rat cerebrum P-1
recombination O-3-6
Reg gene     EL
regeneration EL
regional cerebral glucose metabolism P-13
renal failure     P-2
renin-angiotensin system S-3-1
responder     S-3-4
ryanodine-sensitive calcium store P-4

[S]
SK&F96365     O-1-2
SR59230A     P-8
sarcoplasmic reticulum P-4
sarpogrelate P-15
scabronines     O-2-1
schizophrenic model P-14
smooth muscle cells P-6
smooth muscle relaxant S-1-4
SNP     S-3-4
sphingosine-1-phosphate P-3
spinal ligament cells O-2-4
statins O-2-5
store-operated Ca2+channel O-1-2
stress P-12
stunned myocardium P-2
susceptibility gene S-3-4
sympathetic neuron O-3-5
system A     P-18

[T]
TTX     O-2-2
tail-pressure test     P-10
testis     P-17
thiamine deficiency O-2-3
three-dimensional culture P-6
transcriptome S-3-2
transgenic mice P-20
transgenic mouse O-3-5
transport     P-17
transporter     P-17, P-18, P-19
trapping     O-1-5
type 2 diabetes S-1-3

[V]
V-1 protein     O-3-5
vas deferens P-9
vascular disease     S-1-1
vascular endothelial cells P-3
vascular smooth muscle cells O-3-1
voltage clamp P-7

[W]
Werner's syndrome O-3-6
Wistar Kyoto rat aorta P-4

118:補冊画面に戻る